Quintiles obtuvo la calificación de líder en la industria y ...

StreetInsider.com - Form 10-Q Quintiles Transnational For:

StreetInsider.com - Form 4 Quintiles Transnational For: May 14 Filed by: GILLINGS DENNIS B

Contract research organization Quintiles made its return to the market last week with a nearly $950 million IPO. The largest CRO was acquired by a private equity syndicate that included Bain Capital back in 2008. The private equity firms made a ...

Of the new drugs approved from 2004 through 2011, Quintiles was involved with 85 percent of the central nervous system drugs, 76 percent of oncology drugs and 72 percent of cardiovascular drugs. Mad Money host Jim Cramer explains why the stock is

Sign up for Healthcare Newsletter Print | Share | Reprint by Thomas Zadvydas and Taina Rosa | Published May 10, 2013 at 9:18 AM Private equity-backed Quintiles Transnational Holdings Inc. raised about $947.4 million when it priced its initial public ...

Post a comment Print this blog postE-mail blog post Share Quintiles Chairman Dennis Gillings, center, and CEO Tom Pike, to Gilling's right, join other senior Quintiles executive to ring the "Opening Bell at the New York Stock Exchange on Friday.

NEW YORK (TheDeal) -- Quintiles Transnational Holdings (Q) Shares were little changed Friday at $42.07 after gaining 5.3% on Thursday, the company's debut on the New York Stock Exchange. The offering valued the Durham, N.C.-based provider of ...

Quintiles Transnational (Q) , the drug clinical trials giant, got a decent reception on the NYSE Thursday in a busy day for IPOs. The largest contract research organization's shareholders late Wednesday decided to offer 4 million shares more than ...